Search

Your search keyword '"Schaefer, Franz"' showing total 197 results

Search Constraints

Start Over You searched for: Author "Schaefer, Franz" Remove constraint Author: "Schaefer, Franz" Database Academic Search Index Remove constraint Database: Academic Search Index
197 results on '"Schaefer, Franz"'

Search Results

1. Investigating the use of finerenone in children with chronic kidney disease and proteinuria: design of the FIONA and open-label extension studies.

2. Targeting optimal PD management in children: what have we learned from the IPPN registry?

3. Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working Group.

4. Model‐based approach for methoxy polyethylene glycol‐epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease.

5. Prenatal alcohol exposure affects renal function in overweight schoolchildren: birth cohort analysis.

6. Cardiovascular risk factors in children on dialysis: an update.

7. Tolvaptan use in children and adolescents with autosomal dominant polycystic kidney disease: rationale and design of a two-part, randomized, double-blind, placebo-controlled trial.

8. SGLT2 inhibitors: approved for adults and cats but not for children with CKD.

9. Mortality risk disparities in children receiving chronic renal replacement therapy for the treatment of end-stage renal disease across Europe: an ESPN-ERA/EDTA registry analysis.

10. Normalization of glomerular filtration rate in obese children.

11. Safety and usage of darbepoetin alfa in children with chronic kidney disease: prospective registry study.

12. The incidence and prevalence of IgA nephropathy in Europe.

13. Disparities in treatment rates of paediatric end-stage renal disease across Europe: insights from the ESPN/ERA-EDTA registry.

14. Serum suPAR levels are modulated by immunosuppressive therapy of minimal change nephrotic syndrome.

15. Searching the optimal PTH target range in children undergoing peritoneal dialysis: New insights from international cohort studies.

16. Molecular Adsorbents Recirculating System dialysis in children with cholestatic pruritus.

17. Comparison of Molecular Adsorbents Recirculating System (MARS) dialysis with combined plasma exchange and haemodialysis in children with acute liver failure.

18. Peritoneal dialysis in children with end-stage renal disease.

19. Managing kidney disease with blood-pressure control.

20. Dialysis-associated peritonitis in children.

21. Therapeutic strategies to slow chronic kidney disease progression.

22. Hypertension in children with chronic kidney disease: pathophysiology and management.

23. Neuroendocrine adaptations in renal disease.

24. Management of Peritonitis in Children Receiving Chronic Peritoneal Dialysis.

25. Effects of Growth Hormone in Patients with Chronic Renal Failure: Experience in Children and Adults.

26. Operational description of rare diseases: a reference to improve the recognition and visibility of rare diseases.

27. Characterization of patients with aHUS and associated triggers or clinical conditions: A Global aHUS Registry analysis.

28. Publisher Correction: Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working Group.

29. Estimation of peritoneal mass transport by three-pore model in children.

31. Taking the pulse of a sick kidney: Arterial stiffness in glomerulonephritis.

32. Daily online haemodiafiltration: the perfect ‘stimulus package’ to induce growth?

33. Williams–Beuren syndrome—stretching to learn big lessons from small patients.

34. Clinical practice recommendations for kidney involvement in tuberous sclerosis complex: a consensus statement by the ERKNet Working Group for Autosomal Dominant Structural Kidney Disorders and the ERA Genes & Kidney Working Group.

35. Systematic review on outcomes used in clinical research on autosomal recessive polycystic kidney disease—are patient-centered outcomes our blind spot?

36. Global Variation of Nutritional Status in Children Undergoing Chronic Peritoneal Dialysis: A Longitudinal Study of the International Pediatric Peritoneal Dialysis Network.

37. Pathophysiology and consequences of arterial stiffness in children with chronic kidney disease.

38. Worldwide disparities in access to treatment and investigations for nephropathic cystinosis: a 2023 perspective.

39. Perception and knowledge of pediatric nephrologists on evidence-based guideline development methodology.

40. Real-world evidence on the dosing and safety of C.E.R.A. in pediatric dialysis patients: findings from the International Pediatric Dialysis Network registries.

41. Pediatric peritoneal dialysis training program and its relationship to peritonitis: a study of the International Pediatric Peritoneal Dialysis Network.

42. Prenatal risk factors for kidney and urinary tract anomalies.

43. Unmet needs and challenges for follow-up and treatment of autosomal dominant polycystic kidney disease: the paediatric perspective.

44. IPNA Seventh Symposium on Growth and Development in Children with Chronic Kidney Disease: The Molecular Basis of Skeletal Growth.

45. Together4RD position statement on collaboration between European reference networks and industry.

47. Oxidative stress in children with nephrotic syndrome.

48. Effect of Growth Hormone Treatment on the Adult Height of Children with Chronic Renal Failure.

49. Towards FAIRification of sensitive and fragmented rare disease patient data: challenges and solutions in European reference network registries.

50. Averting the Legacy of Kidney Disease - Focus on Childhood.

Catalog

Books, media, physical & digital resources